IFI-M · PSK Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-01738 // MULTI-AXIS · IFI-M

PSK Tri-Axis Dominant-Primary Series III-PR

Brassica nigra

Black Mustard

Tier IIIPSK Tri-Axis Dominant-Primary Series

Target Trait

1.95×

fold-change

Sharp-dominant tri-axis S+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-01738

Genomic Edits

10

GC Content

44.9%

Construct Length

5,733 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPA1 + TAS1R2/TAS1R3 + CaSR

IFI Score

195

Pathway Edits

  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent PSK pathway operation
  • Cross-pathway regulatory circuit for sharp-dominant PSK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TAS1R2/TAS1R3, and CaSR pathways simultaneously engineeredSharp-dominant tri-axis expression strategy (PSK) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III PSK triple-axis construct for advanced multi-modal sensory architecture combining sharp, sweet, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities